Research opens way to significant improvements for medication
March 27, 2012 in Medical research
International research co-authored by the University of Otago, Christchurch has unraveled a century old scientific mystery, opening the way to significant improvements in the way drugs are delivered to the body.
The research into serum albumin, explains why and how this protein is the most abundant in blood, and will enable medication to be better targeted to the needs of individual patients. The study has recently been published in the prestigious international journal Nature Communications.
This is an exciting development we have worked on for some time and which has just been recognised by the international pharmaceutical industry as a major advance in technology, says Professor Stephen Brennan from the University of Otago, Christchurch.
The research in association with scientists in Norway, the UK and Novozymes Biopharma, has been awarded the premier prize for the most exciting delivery technology of the year at the Drug Delivery Partnerships conference in the USA.
Essentially what our research reveals is a way to develop different variants of the albumin molecule in the blood, to which many drugs bind, and which is used to transport medications around the body.
This means if you want a drug to remain in the body longer for greater effect, or to avoid a patient having to take so many pills or injections, you can adjust the half-life of the albumin molecule to achieve this.
Brennan says this has major implications for better tailoring of medication to specific needs of patients. In particular albumin could be used as a carrier protein for short-lived therapeutic peptides or hormones.
At present it is difficult to determine the most beneficial dosage regimen because the albumin molecules half-life cant be altered. This research changes all that, providing a new pathway to manipulate albumin molecules and adjust a drugs half-life within the patient, allowing improved therapeutic effects.
Scientifically the study shows that albumin molecules, instead of dying and being absorbed by endothelial cells lining the blood vessel, actually bind to a receptor in these cells and are then recycled back into the blood stream.
Weve established for the first time that when the pH inside the cell vesicles drops, then albumin binds to the Fc receptor in the cell, rather like a magnet. The albumin then gets transported back to the surface of the cell, to be released once more into the blood stream to do its work.
Professor Brennan says the discovery of this unique cellular recycling process that maintains the high volume of serum albumin in blood, carrying vital fatty acids, hormones and amino acids around the body, opens the possibility of adjusting albumin molecules to the requirements of specific medications.
Provided by University of Otago
-
High levels of urinary albumin in the normal range predict hypertension
Jun 25, 2008 |
not rated yet |
0
-
Anticancer nanotech
Sep 16, 2009 |
not rated yet |
0
-
Nanoparticles harvest invisible cancer biomarkers
Nov 22, 2011 |
not rated yet |
0
-
Researchers important markers of high risk of type 2 diabetes
Apr 25, 2008 |
not rated yet |
0
-
Uric acid may provide early clues to diabetic kidney disease
Mar 18, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research
May 17, 2013 |
3.7 / 5 (3) |
0
|
SUMO wrestling cells reveal new protective mechanism target for stroke
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research
May 17, 2013 |
5 / 5 (1) |
0
How serotonin receptors can shape drug effects, from LSD to migraine medication
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research
May 17, 2013 |
4 / 5 (1) |
0
|
Preventing blood poisoning
Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.
Medical research
May 17, 2013 |
4 / 5 (1) |
0
|
New mechanism to prevent type 2 diabetes in obese individuals
A new Montréal study conducted by Dr. May Faraj, associate research professor at the Université de Montréal and invited scientist at the IRCM, along with her research team and medical collaborators, shows ...
Medical research
May 17, 2013 |
not rated yet |
0
|
Alzheimer's leaves bilingual victims stranded in Canada
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Research examines new methods for managing digestive health
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
New smartphone application improves colonoscopy preparation
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...